Literature DB >> 15060449

Tenofovir-related nephrotoxicity in HIV-infected patients.

Ana Barrios, Teresa García-Benayas, Juan González-Lahoz, Vincent Soriano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060449     DOI: 10.1097/00002030-200404090-00019

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  23 in total

1.  In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells.

Authors:  Francesc Vidal; Joan Carles Domingo; Jordi Guallar; Maria Saumoy; Begoña Cordobilla; Rainel Sánchez de la Rosa; Marta Giralt; Maria Luisa Alvarez; Miguel López-Dupla; Ferran Torres; Francesc Villarroya; Tomas Cihlar; Pere Domingo
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

2.  Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine.

Authors:  Albert Mwafongo; Kondwani Nkanaunena; Yu Zheng; Evelyn Hogg; Wadzanai Samaneka; Lloyd Mulenga; Abraham Siika; Judith Currier; Shahin Lockman; Michael D Hughes; Mina Hosseinipour
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

3.  Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir.

Authors:  Sabiha Hussain; Abeer Khayat; Asad Tolaymat; Mobeen H Rathore
Journal:  Pediatr Nephrol       Date:  2006-05-16       Impact factor: 3.714

Review 4.  [Antiviral treatment regimens].

Authors:  S Esser
Journal:  Hautarzt       Date:  2006-11       Impact factor: 0.751

5.  Renal disease in patients with HIV.

Authors:  Christina M Wyatt; Jonathan Winston
Journal:  Curr Infect Dis Rep       Date:  2006-01       Impact factor: 3.725

6.  Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA.

Authors:  M Christine Zink; Angela K Brice; Kathleen M Kelly; Suzanne E Queen; Lucio Gama; Ming Li; Robert J Adams; Christopher Bartizal; John Varrone; S Alireza Rabi; David R Graham; Patrick M Tarwater; Joseph L Mankowski; Janice E Clements
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

Review 7.  Urinary biomarkers of kidney diseases in HIV-infected children.

Authors:  Sofia Perazzo; Ángel A Soler-García; Yetrib Hathout; Jharna R Das; Patricio E Ray
Journal:  Proteomics Clin Appl       Date:  2015-06       Impact factor: 3.494

8.  Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS).

Authors:  Ikwo Oboho; Alison G Abraham; Lorie Benning; Kathryn Anastos; Anjali Sharma; Mary Young; Pamela Burian; Monica Gandhi; Mardge Cohen; Lynda Szczech
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-01       Impact factor: 3.731

9.  Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.

Authors:  Clara Y Jones; Camille A Jones; Ira B Wilson; Tamsin A Knox; Andrew S Levey; Donna Spiegelman; Sherwood L Gorbach; Frederick Van Lente; Lesley A Stevens
Journal:  Am J Kidney Dis       Date:  2008-05-02       Impact factor: 8.860

10.  Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort.

Authors:  Arlene C Chua; Ryan M Llorin; Kelvin Lai; Philippe Cavailler; Hwa Lin Law
Journal:  AIDS Res Ther       Date:  2012-06-15       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.